These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37934904)

  • 1. Pharmaceutical co-crystals: A green way to enhance drug stability and solubility for improved therapeutic efficacy.
    Chettri A; Subba A; Singh GP; Bag PP
    J Pharm Pharmacol; 2024 Jan; 76(1):1-12. PubMed ID: 37934904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications.
    Raheem Thayyil A; Juturu T; Nayak S; Kamath S
    Adv Pharm Bull; 2020 Jun; 10(2):203-212. PubMed ID: 32373488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Insight on Pharmaceutical Co-crystals for Improvement of Aqueous Solubility.
    Malik J; Khatkar A; Nanda A
    Curr Drug Targets; 2023; 24(2):157-170. PubMed ID: 36380409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.
    Khan FM; Ahmad M; Idrees HA
    Drug Des Devel Ther; 2020; 14():4303-4313. PubMed ID: 33116417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of solubility enhancement of itroconazole by solid dispersion and co-crystallization technique: Investigation of simultaneous effect of media composition on drug dissolution.
    Rajbhar K; Karodadeo GR; Kumar V; Barethiya V; Lahane A; Kale S; Thakre V; Dixit G; Kohale N; Hiradeve S; Rarokar NR
    Ann Pharm Fr; 2023 Sep; 81(5):843-855. PubMed ID: 37182590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's.
    Kumar A; Kumar M
    Curr Drug Targets; 2023; 24(11):870-888. PubMed ID: 37496134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Characterization of Co-Crystals of Chlordiazepoxide with
    Garbacz P; Paukszta D; Sikorski A; Wesolowski M
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32659986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review.
    Nugrahani I; Jessica MA
    Molecules; 2021 May; 26(11):. PubMed ID: 34071731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods.
    Guo B; Liu H; Li Y; Zhao J; Yang D; Wang X; Zhang T
    Int J Pharm; 2014 Oct; 474(1-2):50-6. PubMed ID: 25108049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the Solubility of Asenapine Maleate Through the Preparation of Co-Crystals.
    Al-Nimry SS; Khanfar MS
    Curr Drug Deliv; 2022; 19(7):788-800. PubMed ID: 34353260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of L-Lysine Amino Acid-Based Co-Crystal of Telmisartan Using Crystal Engineering Approach to Improve Solubility, Dissolution, and Micrometric Properties.
    Bhatt NK; Haneef J; Vyas M; Khatik GL
    Curr Drug Deliv; 2021; 18(5):596-606. PubMed ID: 32881671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Synthesis of Cinnarizine Salt with Malic Acid by Applying Green Chemistry Using Water-Assisted Twin Screw Extrusion.
    Vasoya JM; Lee HL; Lee T; Serajuddin ATM
    Mol Pharm; 2023 Oct; 20(10):5160-5172. PubMed ID: 37646101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of paracetamol-caffeine co-crystals to improve compressional, formulation and in vivo performance.
    Latif S; Abbas N; Hussain A; Arshad MS; Bukhari NI; Afzal H; Riffat S; Ahmad Z
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1099-1108. PubMed ID: 29385849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API co-crystals - Trends in CMC-related aspects of pharmaceutical development beyond solubility.
    Becker A
    Drug Discov Today; 2023 May; 28(5):103527. PubMed ID: 36792006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
    Parmar VK; Shah SA
    Pharm Dev Technol; 2013; 18(2):443-53. PubMed ID: 22686294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomponent crystal compromising dasatinib and selected co-crystals formers: a patent evaluation of EP2861589B1.
    Rathi R; Singh I
    Pharm Pat Anal; 2022 Jan; 11(1):15-21. PubMed ID: 35172634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy.
    Ray E; Vaghasiya K; Sharma A; Shukla R; Khan R; Kumar A; Verma RK
    AAPS PharmSciTech; 2020 Sep; 21(7):260. PubMed ID: 32944787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.